Skip to main content

Table 2 Tumor cell counts, crush artifact or necrotic changes, and sample size for each method

From: A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

 

TBB

(BF: P260F)

TBB

(BF: 1 T260)

TBNA

Core-needle

(CT or US)

Sample number

84

26

23

20

Tumor cell counts

 <100

11

0

0

0

 100, <1000

56

3

14

3

 1000, <2000

14

3

0

5

 2000<

3

20

9

12

 Median

559

6953

1968

6593

 Range

30–3000

380–30,000

100–9000

100–37,500

Crush artifact or necrotic change, %

 <5

15

17

12

14

 5–50

39

6

8

4

 50<

30

3

3

2

Diameter of biopsy sample, mm, mean (95% C.I.)

 Major axis

1.3 (±0.1)

3.2 (±0.9)

1.6 (±0.4)

6.3 (±1.7)

 Minor axis

1.0 (±0.1)

2.2 (±0.6)

1.3 (±0.4)

1.1 (±0.8)

  1. TBB transbronchial biopsy, TBNA transbronchial needle aspiration